- Analytica Investor
- Posts
- π 15% Global Tariff Jolt
π 15% Global Tariff Jolt
Targeted cancer drug developer gained +22% as investors rotated back into development stage biotechs

Good Morning Investors,
Mining and resource linked shares advanced in line with gains across broader commodity gauges, reinforcing the ongoing rotation into tangible asset exposure
Macro and policy developments are now the key swing factors. The surprise move to lift global tariffs to 15% introduces fresh uncertainty for exporters, manufacturers, and retailers.
Governance shifts and evolving board standards may also influence M&A appetite and sentiment toward smaller issuers. Commodity linked names and select growth pockets are attracting capital, but headline risk remains elevated and likely to widen the gap between winners and losers.
Matthias Schneider
Editor at Analytica Investor